- Home
- RUN vs SRRK Comparison
RUN vs SRRK Comparison
Compare RUN & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUN
- SRRK
- Stock Information
- Founded
- RUN 2007
- SRRK 2012
- Country
- RUN United States
- SRRK United States
- Employees
- RUN N/A
- SRRK N/A
- Industry
- RUN Industrial Machinery/Components
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RUN Miscellaneous
- SRRK Health Care
- Exchange
- RUN Nasdaq
- SRRK Nasdaq
- Market Cap
- RUN 3.7B
- SRRK 3.2B
- IPO Year
- RUN 2015
- SRRK 2018
- Fundamental
- Price
- RUN $18.18
- SRRK $31.41
- Analyst Decision
- RUN Buy
- SRRK Strong Buy
- Analyst Count
- RUN 20
- SRRK 8
- Target Price
- RUN $16.12
- SRRK $44.29
- AVG Volume (30 Days)
- RUN 17.4M
- SRRK 1.8M
- Earning Date
- RUN 08-06-2025
- SRRK 08-06-2025
- Dividend Yield
- RUN N/A
- SRRK N/A
- EPS Growth
- RUN N/A
- SRRK N/A
- EPS
- RUN N/A
- SRRK N/A
- Revenue
- RUN $2,129,272,000.00
- SRRK N/A
- Revenue This Year
- RUN $11.84
- SRRK N/A
- Revenue Next Year
- RUN $8.69
- SRRK $3,116.02
- P/E Ratio
- RUN N/A
- SRRK N/A
- Revenue Growth
- RUN 3.27
- SRRK N/A
- 52 Week Low
- RUN $5.38
- SRRK $6.76
- 52 Week High
- RUN $21.77
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- RUN 73.29
- SRRK 41.46
- Support Level
- RUN $14.95
- SRRK $32.16
- Resistance Level
- RUN $16.51
- SRRK $34.66
- Average True Range (ATR)
- RUN 1.06
- SRRK 2.09
- MACD
- RUN 0.11
- SRRK 0.00
- Stochastic Oscillator
- RUN 96.62
- SRRK 28.80
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.